NCT07462663 2026-03-10
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
Clinical Trials
9 trialsNCT07202247 2026-02-04
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
City of Hope Medical Center
Phase 2 Recruiting
NCT05756764 2025-09-09
Anti-obesity Pharmacotherapy and Inflammation
Louisiana State University Health Sciences Center in New Orleans
Active not recruiting
NCT05819853 2025-08-28
RESTORE
University of Colorado, Denver
Phase 3 Recruiting
NCT06908694 2025-07-29
GAINPCCONTROL
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT06896981 2025-04-02
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3 Recruiting
NCT06222437 2024-03-27
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Methodist Health System
Phase 1 Not yet recruiting
NCT05702905 2024-03-25
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Peking University First Hospital
Phase 4 Recruiting
NCT04572165 2024-01-02
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Novo Nordisk A/S
Unknown